IT Solutions
Major LIMS upgrade planned by Genzyme
May 06 2010
The business software strategy provider has inked a deal to oversee the upgrade, the latest in a series of contracts the firm has won with biotech firms.
Following the upgrade to its LIMS, Genzyme's Clinical Specialty Lab is expected to be able to automate a number of its processes that are currently being carried out manually.
Meanwhile, FreshPath adds that the deal is just one of a number that it has agreed to carry out on behalf of Genzyme.
The LIMS upgrade is due to give Genzyme greater process automation by leveraging the features of Blaze Systems' LIMS platform, BlazeLIMS.
Among the capabilities of BlazeLIMS are manufacturing quality control, governmental regulatory compliance, analytical services for commercial laboratories and research and development functions, as well as support for specialty requirements and labs that combine different types of features into a single mode of operation.
Digital Edition
ILM 49.5 July
July 2024
Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...
View all digital editions
Events
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia
Jul 31 2024 Chengdu, China
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Aug 25 2024 Copenhagen, Denmark